menu search

GIS / General Mills Retreats To Buy Zone Ahead Of Earnings

General Mills Retreats To Buy Zone Ahead Of Earnings
General Mills (NYSE: GIS) advanced to a new all-time high following the FQ2 earnings release but has since retreated to retest support. The set-up has the market trading at the 150-day EMA and ready to fire another trend-following signal. Read More
Posted: Mar 20 2023, 11:11
Author Name: MarketBeat
Views: 111647

GIS News  

Hold On To General Mills To Get A Healthy Dividend Yield For Breakfast

By Seeking Alpha
November 2, 2023

Hold On To General Mills To Get A Healthy Dividend Yield For Breakfast

General Mills rated neutral/hold today, in line with the consensus from analysts and the quant system. Positive points include a 3.6% dividend yield w more_horizontal

General Mills (GIS) Stock Sinks As Market Gains: Here's Why

By Zacks Investment Research
November 1, 2023

General Mills (GIS) Stock Sinks As Market Gains: Here's Why

General Mills (GIS) concluded the recent trading session at $65.10, signifying a -0.21% move from its prior day's close. more_horizontal

Food consumption currently driven by ‘value seeking behavior': General Mills Retail President

By Yahoo Finance
October 17, 2023

Food consumption currently driven by ‘value seeking behavior': General Mills Retail President

"Consumer spending appears to be consistent, with many having more income to dine out. What does impact does that have on the snacking and cereal busi more_horizontal

Will General Mills (GIS) Accelerate Strategy Aid Amid Cost Woes?

By Zacks Investment Research
October 11, 2023

Will General Mills (GIS) Accelerate Strategy Aid Amid Cost Woes?

General Mills (GIS) benefits from its Accelerate strategy and favorable net price realization amid cost inflation. more_horizontal

General Mills: Down 30% And Approaching Sale Aisle

By Seeking Alpha
October 2, 2023

General Mills: Down 30% And Approaching Sale Aisle

General Mills: Down 30% And Approaching Sale Aisle more_horizontal

Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom

By CNBC
October 1, 2023

Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom

Kellogg, J.M. Smucker and other food companies are making big bets on snacking, but the rise of Wegovy and Ozempic could pose a threat to future sales more_horizontal

General Mills: Still A Tough Place

By Seeking Alpha
October 1, 2023

General Mills: Still A Tough Place

General Mills is facing volume challenges and weaker underlying trends, leading to a re-rating of its stock. General Mills' first quarter sales increa more_horizontal

Down About 30%, Yielding 4% - How Attractive Is General Mills?

By Seeking Alpha
October 1, 2023

Down About 30%, Yielding 4% - How Attractive Is General Mills?

General Mills faces challenges with its stock price due to concerns over inflation and declining consumer confidence. The company's 1Q24 results showe more_horizontal


Search within

Pages Search Results: